awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33805555-6D9B7BAE-D98A-4204-9DFB-25D316D7D80F
Q33805555-6D9B7BAE-D98A-4204-9DFB-25D316D7D80F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33805555-6D9B7BAE-D98A-4204-9DFB-25D316D7D80F
Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study.
P2860
Q33805555-6D9B7BAE-D98A-4204-9DFB-25D316D7D80F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33805555-6D9B7BAE-D98A-4204-9DFB-25D316D7D80F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8bf5e117acd7352e019fd67f466f0698aa43ab16
P2860
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study.